Abstract
Tigecycline is a novel antimicrobial agent for parenteral use encompassing a broad spectrum of bacterial pathogens, including multi-resistant organisms. Here, we report the results of the first nationwide surveillance trial that was conducted in order to evaluate the susceptibility of bacterial isolates to tigecycline in a European country prior to its clinical use. A total of 2,610 Gram-positive and Gram-negative organisms recovered from hospitalized patients were tested. Minimum inhibitory concentrations (MICs) were determined using the microdilution method. All enterococci, staphylococci (including methicillin-resistant Staphylococcus aureus; MRSA), and streptococci tested were tigecycline-susceptible, except one isolate of Staphylococcus haemolyticus. Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum beta-lactamase [ESBL]-producers) were tigecycline-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant. Based on the results of this surveillance study, tigecycline may represent a suitable option most notably for the empiric treatment of bacterial mixed infections, including in clinical situations in which multi-resistant o...Continue Reading
References
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·P J PetersenR T Testa
Jul 8, 2000·Infection·M Kresken, D Hafner
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Ad C FluitDana Milatovic
May 14, 2005·International Journal of Antimicrobial Agents·Alan P JohnsonRobert C George
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia A BradfordPeter J Petersen
Aug 18, 2005·Diagnostic Microbiology and Infectious Disease·Daryl J HobanUNKNOWN Tigecycline Evaluation and Surveillance Trial (TEST Program) Group
Aug 27, 2005·The Journal of Antimicrobial Chemotherapy·David M Livermore
Jul 5, 2006·Seminars in Pediatric Surgery·Joseph F BuellE Steve Woodle
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·Ken B WaitesMichael J Dowzicky
Oct 27, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Jan 19, 2007·The Journal of Antimicrobial Chemotherapy·Neil WoodfordDavid M Livermore
Aug 31, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F DrobniewskiUNKNOWN Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobi
Feb 21, 2008·The Journal of Antimicrobial Chemotherapy·Guido WernerIngo Klare
Sep 8, 2009·The American Journal of Cardiology·William B WhiteMaarten Beekman
Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Po-Ren HsuehLee-Jene Teng
Citations
Mar 20, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KreskenC von Eiff
Mar 4, 2011·Der Unfallchirurg·P Kujath, H Shekarriz
Feb 25, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KreskenUNKNOWN Study Group
Dec 27, 2011·Pathologie-biologie·C BrisM Kempf
Nov 5, 2014·Infection·W R HeizmannC Petrik
Jul 23, 2011·Chemotherapy·Christian EckmannKlaus-Friedrich Bodmann
Jul 27, 2012·Chemotherapy·Matthias WienkeSabine Gröbner
Apr 5, 2013·Clinical Microbiology Reviews·Alejandro BeceiroGermán Bou
Dec 18, 2010·European Journal of Medical Research·Christian Eckmann, M Dryden